Dynamic distribution and expression in vivo of the human interferon gamma gene delivered by adenoviral vector

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Wu, Jiangxue ^a   Xiao, Xia ^a   Jia, Hongyun ^a,c   Chen, Jiemin ^a   Zhu, Yinghui ^a   Zhao, Peng ^a   Lin, Huanxin ^a   Huang, Wenlin ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b INSTITUTE OF MICROBIOLOGY   (China)

^c GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; COMPLEMENTARY DNA; GAMMA INTERFERON; HYBRID PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GENE THERAPY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG LIVER LEVEL; DRUG TISSUE LEVEL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; ADENOVIRUS; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENE THERAPY; GENE VECTOR; GENETICS; INJECTION; KIDNEY; LIVER; METABOLISM; METHODOLOGY; NASOPHARYNX TUMOR; NUDE MOUSE; PATHOLOGY; POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ADENOVIRIDAE; ANIMALS; CELL LINE; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENETIC VECTORS; HUMANS; INJECTIONS; INTERFERON-GAMMA; KIDNEY; LIVER; MICE; MICE, INBRED BALB C; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; POLYMERASE CHAIN REACTION; RECOMBINANT FUSION PROTEINS; TISSUE DISTRIBUTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 65349097471     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-55     Document Type: Article

References (22)

1. Younes HM Amsden BG Interferon-gamma therapy: Evaluation of routes of administration and delivery systems J Pharm Sci 2002, 91(1):2-17 11782893 10.1002/jps.10007
2. Pang KR Wu JJ Huang DB Tyring SK Baron S Biological and clinical basis for molecular studies of interferons Methods Mol Med 2005, 116:1-23 16007741
3. Liu M Acres B Balloul JM Bizouarne N Paul S Slos P et al Gene-based vaccines and immunotherapeutics Proc Natl Acad Sci U S A 2004, 101(Suppl 2):14567-14571 15333750 521989 10.1073/pnas.0404845101
4. Chada S Ramesh R Mhashilkar AM Cytokine- and chemokine-based gene therapy for cancer Curr Opin Mol Ther 2003, 5(5):463-474 14601514
5. Chan AT Teo PM Huang DP Pathogenesis and treatment of nasopharyngeal carcinoma Semin Oncol 2004, 31(6):794-801 15599857 10.1053/ j.seminoncol.2004.09.008
6. Wu JX Xiao X Zhao P Xue G Zhu YH Zhu XF et al Minicircle-IFNγ Induces Anti-proliferative and Anti-tumoral Effects in Human Nasopharyngeal Carcinoma Clinical Cancer Res 2006, 15:4702-13 10.1158/ 1078-0432.CCR-06-0520
7. Zhao P Zhu Y Wu J Liu R Zhu X Xiao X et al Adenovirus-mediated delivery of human IFNgamma gene inhibits prostate cancer growth Life Sci 2007, 81(9):695-701 17714738 10.1016/j.lfs.2007.05.028
8. Graham FL Prevec L Methods for construction of adenovirus vectors Mol Biotechnol 1995, 3(3):207-220 7552690
9. Spano JP Busson P Atlan D Bourhis J Pignon JP Esteban C Nasopharyngeal carcinomas: An update Eur J Cancer 2003, 39(15):2121-2135 14522369 10.1016/S0959-8049(03)00367-8
10. Young LS Murray PG Epstein-Barr virus and oncogenesis: From latent genes to tumours Oncogene 2003, 22(33):5108-5121 12910248 10.1038/ sj.onc.1206556
11. Wakisaka N Pagano JS Epstein-Barr virus induces invasion and metastasis factors Anticancer Res 2003, 23:2133-2138 12894587
12. Weinrib L Li JH Donovan J Huang D Liu FF Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma Cancer Gene Ther 2001, 8(5):352-360 11477455 10.1038/ sj.cgt.7700319
13. Li JH Lax SA Kim J Klamut H Liu FF The effects of combining ionizing radiation and adenoviral p53 therapy in nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 1999, 43(3):607-616 10078646
14. Li JH Shi W Chia M Sanchez-Sweatman O Siatskas C Huang D et al Efficacy of targeted FasL in nasopharyngeal carcinoma Mol Ther 2003, 8(6):964-973 14664799 10.1016/j.ymthe.2003.08.018
15. Lu Y Carraher J Zhang Y Armstrong J Lerner J Rogers WP et al Delivery of adenoviral vectors to the prostate for gene therapy Cancer Gene Ther 1999, 6:64-72 10.1038/sj.cgt.7700011 10078965
16. Rein DT Breidenbach M Curiel DT Current developments in adenovirus-based cancer gene therapy Future Oncol 2006, 2(1):137-143 16556080 1781528 10.2217/14796694.2.1.137
17. Lohr F Huang Q Hu K Dewhirst MW Li CY Systemic vector leakage and transgene expression by intratumorally injected recombinant adenovirus vectors Clin Cancer Res 2001, 7(11):3625-3628 11705885
18. Paielli DL Wing MS Rogulski KR Gilbert JD Kolozsvary A Kim JH et al Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse Mol Ther 2000, 1(3):263-274 10933942 10.1006/mthe.2000.0037
19. Wang Y Hu JK Krol A Li YP Li CY Yuan F Systemic dissemination of viral vectors during intratumoral injection Mol Cancer Ther 2003, 2(11):1233-1242 14617797
20. Wang Y Yang Z Liu S Kon T Krol A Li CY et al Characterisation of systemic dissemination of nonreplicating adenoviral vectors from tumours in local gene delivery Br J Cancer 2005, 92(8):1414-1420 15812558 10.1038/sj.bjc.6602494
21. Xu Z Tian J Smith JS Byrnes AP Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies and complement J Virol 2008, 82(23):11705-11713 18815305 10.1128/JVI.01320-08
22. Smith JS Xu Z Tian J Stevenson SC Byrnes AP Interaction of systemically delivered adenovirus vectors with Kupffer cells in mouse liver Hum Gene Ther 2008, 19(5):547-54 18447633 10.1089/hum.2008.004